Genen­tech, Gilead push FDA to mod­ern­ize re­search in­spec­tions

Roche’s Genen­tech, Gilead, Sanofi and oth­er drug­mak­ers weighed in on the FDA’s re­cent draft guid­ance on re­search in­spec­tions, with the com­pa­nies call­ing for clar­i­ty and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER